| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 42 |
| 1 | LETROZOLE | 27 |
| 2 | CARBOPLATIN | 24 |
| 3 | LETROZOLE TABLETS | 22 |
| 4 | OXALIPLATIN | 16 |
| 5 | ANASTROZOLE | 14 |
| 6 | ANASTROZOLE TABLETS | 14 |
| 7 | DOXORUBICIN | 14 |
| 8 | ENALAPRIL | 14 |
| 9 | LEVOTHYROXINE SODIUM | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIV-AFLIBERCEPT | 1 | 0.0008 |
| 1 | ANASTROZOLE TABLETS | 14 | 0.0006 |
| 2 | CALCIUM FOLINATE | 3 | 0.0006 |
| 3 | EXEMESTANE | 13 | 0.0006 |
| 4 | LETROZOLE TABLETS | 22 | 0.0004 |
| 5 | LETROZOLE | 27 | 0.0004 |
| 6 | VINORELBINE | 3 | 0.0004 |
| 7 | DOXORUBICIN HYDROCHLORIDE | 13 | 0.0004 |
| 8 | ANASTROZOLE | 14 | 0.0004 |
| 9 | SITAGLIPTIN PHOSPHATE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 13 | 0.0003 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 44 | 0.0002 |
| 3 | Aromatase Inhibitor [EPC] | 27 | 0.0002 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 5 | Platinum-based Drug [EPC] | 42 | 0.0002 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 9 | 0.0001 |
| 8 | Aldosterone Antagonist [EPC] | 14 | 0.0001 |
| 9 | Microtubule Inhibitor [EPC] | 13 | 0.0001 |